MedTrace Logo

Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer Disease

NCT04771845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2021-02-25

No results posted yet for this study

Summary

The investigators reviewed 12 years of clinical use in an outpatient neurology setting of transcranial magnetic stimulation (TMS) in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) to evaluate safety and efficacy of TMS.

Conditions

Interventions

DEVICE

Transcranial Magnetic Stimulation

Magnetic stimulation to alter neural activity

Sponsors & Collaborators

  • The New York Memory Services

    lead OTHER

Principal Investigators

  • Gayatri Devi, MD · NY Memory

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-01
Primary Completion
2020-05-30
Completion
2020-05-30
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771845 on ClinicalTrials.gov